-
Mashup Score: 13
When Sue Vincent learned in 2010 that her ovarian cancer had spread to three different parts of her body and was inoperable, she resigned herself to having only months to live. But then she was offered a place on a clinical trial for a pioneering drug called olaparib, the discovery and development of which was underpinned by our research. 12 years on, Sue is still taking olaparib, and explains how the work of our scientists has given her a quality of life she could only have dreamed about.
Source: www.icr.ac.ukCategories: General Medicine News, Onc News and JournalsTweet
Fourteen years ago Sue Vincent learned that her #OvarianCancer had spread, and was inoperable. But then she was offered a place on a clinical trial for a pioneering drug called olaparib. Read her story of hope this #OvarianCancerAwarenessMonth 👇 https://t.co/Li7whmj2TX